哪来的垃圾新闻，驴头_老虎社区_美港股上老虎 - 老虎社区

点赞
评论
收藏

破碎的玻璃
2024-09-21

哪来的垃圾新闻，驴头不对马嘴

异动解读 | 医药创新驱动力强劲药明康德股价大涨5%

今日药明康德开盘后一路高涨,午后股价大涨5.12%,报收于51.25港元,引发市场广泛关注。分析人士认为,作为全球领先的医药研发服务公司,药明康德日渐增强的创新实力和广阔市场空间或是支撑这轮上涨的主因。国内医药创新相关政策陆续落地,医药科技创新成为国家重点支持的产业方向。近期药明康德的创新药品研发取得重大进展,提振了市场信心。此外,新冠疫情防控常态化有助于药明康德业务的高质量增长,国内外业务区域有望进一步协同发展。公司积极推进产业多元化,新产品线有望为后续增长注入新动力。

异动解读 | 医药创新驱动力强劲药明康德股价大涨5%

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

点赞

举报

评论

推荐
最新

empty

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":351473783939280,"tweetId":"351473783939280","gmtCreate":1726848159749,"gmtModify":1726848232962,"author":{"id":3451680862549735,"idStr":"3451680862549735","authorId":3451680862549735,"authorIdStr":"3451680862549735","name":"破碎的玻璃","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":10,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>哪来的垃圾新闻，驴头不对马嘴</p></body></html>","htmlText":"<html><head></head><body><p>哪来的垃圾新闻，驴头不对马嘴</p></body></html>","text":"哪来的垃圾新闻，驴头不对马嘴","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/351473783939280","repostId":1141934662,"repostType":2,"repost":{"id":"1141934662","kind":"news","weMediaInfo":{"introduction":"个股异动一手消息解读","home_visible":1,"media_name":"异动解读","id":"1092702339","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"pubTimestamp":1726816846,"share":"https://www.laohu8.com/m/news/1141934662?lang=&edition=full","pubTime":"2024-09-20 15:20","market":"hk","language":"zh","title":"异动解读 | 医药创新驱动力强劲 药明康德股价大涨5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1141934662","media":"异动解读","summary":"今日药明康德开盘后一路高涨,午后股价大涨5.12%,报收于51.25港元,引发市场广泛关注。\n        分析人士认为,作为全球领先的医药研发服务公司,药明康德日渐增强的创新实力和广阔市场空间或是支撑这轮上涨的主因。国内医药创新相关政策陆续落地,医药科技创新成为国家重点支持的产业方向。近期药明康德的创新药品研发取得重大进展,提振了市场信心。\n        此外,新冠疫情防控常态化有助于药明康德业务的高质量增长,国内外业务区域有望进一步协同发展。公司积极推进产业多元化,新产品线有望为后续增长注入新动力。","content":"<p>今日药明康德开盘后一路高涨,午后股价大涨5.12%,报收于51.25港元,引发市场广泛关注。</p>\n        <p>分析人士认为,作为全球领先的医药研发服务公司,药明康德日渐增强的创新实力和广阔市场空间或是支撑这轮上涨的主因。国内医药创新相关政策陆续落地,医药科技创新成为国家重点支持的产业方向。近期药明康德的创新药品研发取得重大进展,提振了市场信心。</p>\n        <p>此外,新冠疫情防控常态化有助于药明康德业务的高质量增长,国内外业务区域有望进一步协同发展。公司积极推进产业多元化,新产品线有望为后续增长注入新动力。</p>","source":"ai_movement_cn","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读 | 医药创新驱动力强劲 药明康德股价大涨5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读 | 医药创新驱动力强劲 药明康德股价大涨5%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092702339\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">异动解读 </p>\n<p class=\"h-time\">2024-09-20 15:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>今日药明康德开盘后一路高涨,午后股价大涨5.12%,报收于51.25港元,引发市场广泛关注。</p>\n        <p>分析人士认为,作为全球领先的医药研发服务公司,药明康德日渐增强的创新实力和广阔市场空间或是支撑这轮上涨的主因。国内医药创新相关政策陆续落地,医药科技创新成为国家重点支持的产业方向。近期药明康德的创新药品研发取得重大进展,提振了市场信心。</p>\n        <p>此外,新冠疫情防控常态化有助于药明康德业务的高质量增长,国内外业务区域有望进一步协同发展。公司积极推进产业多元化,新产品线有望为后续增长注入新动力。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"02359":"药明康德"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1141934662","content_text":"今日药明康德开盘后一路高涨,午后股价大涨5.12%,报收于51.25港元,引发市场广泛关注。\n分析人士认为,作为全球领先的医药研发服务公司,药明康德日渐增强的创新实力和广阔市场空间或是支撑这轮上涨的主因。国内医药创新相关政策陆续落地,医药科技创新成为国家重点支持的产业方向。近期药明康德的创新药品研发取得重大进展,提振了市场信心。\n此外,新冠疫情防控常态化有助于药明康德业务的高质量增长,国内外业务区域有望进一步协同发展。公司积极推进产业多元化,新产品线有望为后续增长注入新动力。","news_type":1},"isVote":1,"tweetType":1,"viewCount":995,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":27,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}